RheumaGen logo

RheumaGen

Denver, CO

RheumaGen is a gene-editing technology developing therapeutics to cure rheumatoid arthritis. It offers an HLA gene-editing platform that uses stem-cell-enriched blood to alter DNA to suppress the immune system and stop rheumatoid arthritis's abnormal immune response.

rheumagen.com

Company Details

Founded

2019

Employees

Between 5 - 10 employees

Raised

$19,906,588

Headquarters Location

Denver, CO

Public

No

Acquired

No

CEO

Richard Freed

Founders

Brian Hart
Brian Hart

Company Collections

These are collections RheumaGen is a part of. Click on the collection name to view similar companies.

RheumaGen's Industries

RheumaGen Headquarters Location

200 Quebec St bldg. 600 ste. 205, Denver, CO 80230

Total Amount Raised: $19,906,588

RheumaGen Funding Rounds

  • Series A

    $15,000,000

    Series A Investors

    SPRIM Global Investments
    William Taylor Nominees

  • Series Unknown

    $4,906,587

Funding info provided by Diffbot.

RheumaGen Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on RheumaGen.

Recent reviews